Lenalidomide and R-CHOP in B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
- Status
- TERMINATED
- Phase
- NA
Zevalin® First Line in Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Therapy Treatment in Patients With Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of VR-CHOP in Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Idiotypic Vaccination for Follicular Lymphoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2